Myriad Says Study Supports Routine BRCA Testing in Women with Triple-Negative Breast Cancer

Since a preliminary 77-patient study presented at an ASCO meeting this week suggested that TNBC patients with BRCA mutations had "a significantly better" relapse-free survival rate compared to wild-type patients, Myriad feels that treatment guidelines should be changed to recommend routine BRACAnalysis testing for women with this type of cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.